US2001056255A1PendingUtilityA1
Effect of electric field and ultrasound for transdermal drug delivery
Priority: Dec 18, 1995Filed: Mar 20, 2000Published: Dec 27, 2001
Est. expiryDec 18, 2015(expired)· nominal 20-yr term from priority
A61N 1/042A61K 9/0009A61N 1/325A61M 2037/0007A61M 37/0092A61N 1/327A61B 5/14514A61N 1/0428A61N 1/0412A61K 41/0047
40
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Transdermal transport of molecules during sonophoresis (delivery or extraction) can be further enhanced by application of an electric field, for example, electroporation or iontophoresis. In a preferred embodiment the ultrasound is low frequency ultrasound which induces cavitation of the lipid layers of the stratum corneum (SC). This method provides higher drug transdermal fluxes, allows rapid control of transdermal fluxes, and allows drug delivery or analyte extraction at lower ultrasound intensities than when ultrasound is applied in the absence of an electric field.
Claims
exact text as granted — not AI-modifiedWe claim:
1 . A method for enhancing transdermal transport of compounds comprising administering to the skin an effective amount of ultrasound in combination with an electric field.
2 . The method of claim 1 wherein the ultrasound is administered at a frequency of less than 2.5 MHz.
3 . The method of claim 1 wherein the ultrasound is administered at a frequency of 1 MHz or less.
4 . The method of claim 1 wherein the intensity of the ultrasound is less than 2.5 W/cm 2 .
5 . The method of claim 1 wherein the intensity of the ultrasound is less than 1.5 W/cm 2 .
6 . The method of claim 1 wherein the ultrasound is administered with agents enhancing solubility of the compounds to be transported in combination with agents enhancing the fluidity of lipid bilayers.
7 . The method of claim 1 wherein the ultrasound is administered in combination with an electric force field selected from the group consisting of electroporation and iontophoresis.
8 . The method of claim 1 wherein the compound to be transported is a drug the patient is in need of.
9 . The method of claim 1 wherein the compound to be transported is an analyte to be measured.
10 . The method of claim 1 wherein the electric field is pulsed.
11 . The method of claim 1 wherein the ultrasound is pulsed.
12 . An apparatus for applying ultrasound and an electric field to skin in an amount effect to enhance transport of molecules through the skin without damaging the skin.Join the waitlist — get patent alerts
Track US2001056255A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.